Medicine
HyperTET 250 IU/mL injection
HyperTET 250 IU/mL injection is a prescription medicine containing Human clostridium tetani toxoid immune globulin for intramuscular use, marketed by Grifols, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 2–8°C (36–46°F).
Key facts
- Active ingredient (INN)
- Human clostridium tetani toxoid immune globulin
- Brand
- HyperTET
- Strength
- 250 IU/mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 syringe
- Marketing authorisation holder
- Grifols
- Manufacturer
- Grifols
- Origin register
- US FDA, United States
- Storage
- Store at 2–8°C (36–46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 August 1996
- Identifiers
- DailyMed set ID 393fa198-7e07-4162-bd0a-9d873f1544a9NDC 13533-634Application BLA101142
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 box / 1 mL in 1 syringe, glass | 13533-634-02 | Grifols | 14 August 1996 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Human clostridium tetani toxoid immune globulin is a prescription medicine indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain. MedsAcross supplies Human clostridium tetani toxoid immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human clostridium tetani toxoid immune globulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- HyperTET prescribing information (Grifols) · U.S. National Library of Medicine, DailyMed
Need HyperTET 250 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.